
The medication
Compounded semaglutide
A GLP-1 receptor agonist prepared by a state-licensed 503A pharmacy on a per-prescription basis. Shipped discreetly after provider authorization.
Medical wellness programs
A glucagon-like peptide-1 (GLP-1) receptor agonist, prepared by a state-licensed 503A compounding pharmacy when your provider determines it fits your medical history. Available via telehealth in Michigan, Florida, Alabama, and Mississippi. Free 20-minute consultation.

Compounded Semaglutide
from $125/mo
Medication, monthly check-ins, labs and dose titration.
Medically reviewed by
Dr. Erald Lula, MD, MPH
Triple Board-Certified: Internal Medicine, Obesity Medicine, Lifestyle Medicine
Last reviewed: Bio
NuHealth’s semaglutide program is a program, not a prescription. Every plan combines the compounded medication, supervised provider care, and the lab + dose monitoring that makes a GLP-1 program safe over time.

The medication
A GLP-1 receptor agonist prepared by a state-licensed 503A pharmacy on a per-prescription basis. Shipped discreetly after provider authorization.
The provider
Licensed in your state. Free 20-minute consultation reviewing your full medical history. Monthly check-ins and direct provider messaging.
The monitoring
Baseline labs before any prescription. Gradual titration over the first 12 weeks. Quarterly labs and response tracking with your provider.
“Pricing posted up front: Compounded Semaglutide at $125 / month. Your provider determines whether a personalized compounded program is clinically appropriate for you at the consultation.”
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist — a class of medication that works with your body’s natural appetite-regulation pathways. It signals fullness sooner, slows how quickly your stomach empties, and helps stabilize blood sugar between meals.
A “compounded” medication is one prepared by a state-licensed compounding pharmacy on a prescription-by-prescription basis. NuHealth’s compounded semaglutide is prepared by a 503A compounding pharmacy when your NuHealth provider determines that a personalized formulation fits your clinical situation. This per-patient framework is what allows ongoing compounding of semaglutide under current FDA rules.
Compounded semaglutide is not FDA-approved as a finished drug product. Your NuHealth provider will explain how this affects your treatment plan during your consultation.

How it works in the body
Appetite signal
Acts on receptors that quiet hunger cues.
Slowed gastric emptying
You stay fuller for longer between meals.
Blood sugar stability
Helps level the glucose curve through the day.

A board-certified physician reviews your medical history, weight history, goals, and any medications or conditions that may affect candidacy. If you are not a candidate for a compounded semaglutide program, your provider will discuss alternatives. The consultation itself is free.

Your provider orders baseline labs (typically metabolic panel, A1C, thyroid, and kidney function), reviews your results, and confirms whether a personalized compounded program is appropriate for your situation. If your provider authorizes treatment, your prescription is sent to our 503A compounding pharmacy partner.

Monthly check-ins with your provider. Quarterly labs to monitor how your body is responding. Your provider adjusts dose, slows titration, or recommends a different protocol entirely if side effects are limiting. You can message your provider directly between appointments.
Throughout, your treatment plan is the responsibility of your NuHealth provider — informed by your full medical history, labs, and response to treatment.
Compounded semaglutide may be appropriate for adults whose provider determines that the medication fits their clinical situation. Here is how candidacy is generally framed before your consultation.
Your NuHealth provider makes the final candidacy determination after reviewing your complete medical history, current medications, and baseline labs.
Many patients describe a quieting of food noise — the persistent, low-level mental preoccupation with food and eating that makes changing habits so difficult. Individual response varies; your provider tracks your specific timeline at every check-in.
Weeks 1–2
Starting dose · 0.25 mg weekly
Your provider starts low (0.25 mg weekly) so your body adjusts. Many patients describe early appetite changes; mild nausea is the most common side effect and usually resolves.
Week 4
First titration step
If the starting dose is well-tolerated, your provider may step you up. A check-in confirms how your body responds.
Week 12
Full program rhythm
By three months, many patients have settled into a stable dose with their provider. Your provider reviews progress, side effects, and labs.
Week 24
Outcomes review
Around six months your provider does a full outcomes review. Some patients move to a lower-dose maintenance phase; others continue on the active program.
The pattern above is what patients commonly describe. It is not a guarantee of outcome. Your provider tailors the plan to your specific metabolic profile, labs, and goals.
The program at a glance
Your provider starts you at a low dose and increases it gradually, reviewing how you respond at every check-in. Compounded semaglutide is prepared per-patient by a state-licensed 503A pharmacy. Individual results vary — your plan is built around your biology, under medical supervision.
Pharmacy
503A
State-licensed compounding
States
4
MI · FL · AL · MS
Google rating
5.0★
From verified patients
Provider response
<24h
Typical reply time on the patient portal

The medication
Compounded semaglutide
Prepared to your provider’s prescription by a state-licensed 503A compounding pharmacy.
Free 20-minute consultation · Provider determines candidacy
The compounded semaglutide program covers the medication, provider check-ins, labs, and dose titration. If your provider recommends a different molecule, the tirzepatide program follows the same shape at a different price.
Best for most patients
3-month starter program
Next-generation dual mechanism
3-month starter program
A free 20-minute provider consultation precedes any prescription.
CareCredit · Financing partner
GLP-1 programs run $125–$265 a month. With CareCredit, split the medication, labs, and follow-through over a longer schedule. Prequalification has no impact on your credit score.
Check your prequalificationCareCredit is a financing product from Synchrony Bank. NuHealth Medical Wellness does not own, operate, or set the terms of CareCredit. Approval, rates, and terms are determined by Synchrony at application.

The medication ships to your door. When you need to walk in for labs, an in-person visit, or a dose discussion, our Royal Oak clinic is on Woodward, between Birmingham and Berkley.
NuHealth Medical Wellness30301 Woodward Ave, Suite 240Three topics, in plain language. If you do not see your question, the free consultation is the place to ask it.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. A compounded preparation is one prepared by a state-licensed compounding pharmacy on a per-prescription basis. NuHealth’s compounded semaglutide is prepared by our 503A pharmacy partner when your provider determines a personalized formulation is appropriate for your situation. It is not FDA-approved as a finished drug product.
Many patients describe noticing appetite changes within the first 1–2 weeks. Measurable changes typically appear later. Your provider tracks your specific timeline at every check-in. Individual response varies.
If you remember within 5 days of your scheduled dose, take it as soon as you remember and continue your normal schedule. If more than 5 days have passed, skip the missed dose and continue with your next scheduled one. Don’t double up. If you have questions about dosing, message your provider.
$125/month. The monthly price includes the medication (when prescribed), provider check-ins, lab orders, dose titration, and direct provider messaging. The 20-minute provider consultation is free. NuHealth does not bill insurance.
NuHealth is a cash-pay model, so coverage changes do not affect your eligibility or pricing here. Your provider’s decision to recommend a personalized program is based on your medical history, not your insurance status. Bring any questions about your previous treatment to your consultation.
No. NuHealth’s compounded semaglutide is not Wegovy® or Ozempic®. Those are FDA-approved finished drug products manufactured and tested by Novo Nordisk. NuHealth’s compounded semaglutide is prepared by a state-licensed 503A compounding pharmacy on a per-prescription basis and is not FDA-approved as a finished drug product. Clinical-trial outcomes from FDA-approved branded products do not transfer to compounded preparations. Your provider will explain the distinction during your consultation.
Yes — semaglutide is a subcutaneous injection, given once a week. The needles are very fine (similar to insulin pens). Your provider walks you through the technique at your first appointment.
Many patients regain some weight when they stop. Your provider will work with you on a tapering plan if you decide to discontinue. Some patients move to a lower-dose maintenance schedule with their provider; others step down over months as lifestyle changes take hold. The plan is individualized.
From a patient
“I had tried every diet. Nothing stuck until this — and it’s not about willpower, it’s about biology finally cooperating.”
Sarah M.
Semaglutide Program
Starting
268 lbs
Current
221 lbs
12 weeks in program

The next step
NuHealth provides telehealth care to adults in Michigan, Florida, Alabama, and Mississippi, with in-person consultations available at our Royal Oak, MI clinic. Start with a free 20-minute consultation. Your provider determines candidacy and treatment plan based on your medical history.
Or join NuHealth+ from $99/mo and save 15% on this program.